---
figid: PMC4156720__pnas.1413363111fig01
figlink: /pmc/articles/PMC4156720/figure/fig01/
number: F1
caption: Cotargeting the PI3K/AKT and AR pathways in CRPC. The administration of AR-targeted
  agents such as abiraterone acetate and enzalutamide is thought to promote the development
  of castration resistance due to the loss of negative feedback regulation of the
  PI3K/AKT pathway. The development of the PIP5K1α inhibitor, ISA-2011B, adds another
  tool for targeting the PI3K pathway, as well as provide the impetus to cotarget
  with inhibitors of RTK and AR signaling pathways in CRPC. TKI, tyrosine kinase inhibitor.
pmcid: PMC4156720
papertitle: PIP5K1α inhibition as a therapeutic strategy for prostate cancer.
reftext: Justin M. Drake, et al. Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12578-12579.
pmc_ranked_result_index: '20997'
pathway_score: 0.9349145
filename: pnas.1413363111fig01.jpg
figtitle: Cotargeting the PI3K/AKT and AR pathways in CRPC
year: '2014'
organisms: Homo sapiens
ndex: 7bfff234-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4156720__pnas.1413363111fig01.html
  '@type': Dataset
  description: Cotargeting the PI3K/AKT and AR pathways in CRPC. The administration
    of AR-targeted agents such as abiraterone acetate and enzalutamide is thought
    to promote the development of castration resistance due to the loss of negative
    feedback regulation of the PI3K/AKT pathway. The development of the PIP5K1α inhibitor,
    ISA-2011B, adds another tool for targeting the PI3K pathway, as well as provide
    the impetus to cotarget with inhibitors of RTK and AR signaling pathways in CRPC.
    TKI, tyrosine kinase inhibitor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - PIK3CD
  - AKT3
  - MTOR
  - RPTOR
  - PIK3R5
  - PIK3CB
  - AR
  - PIK3R4
  - PHLPP1
  - PIK3R6
  - FKBP5
  - PIK3CG
  - PIK3R3
  - PIK3CA
  - PTEN
  - Abiraterone
  - Enzalutamide
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC1/2'
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1/2'
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PHLPP
  symbol: PHLPP
  source: hgnc_prev_symbol
  hgnc_symbol: PHLPP1
  entrez: '23239'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: FKBP5
  symbol: FKBP5
  source: hgnc_symbol
  hgnc_symbol: FKBP5
  entrez: '2289'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals:
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: Enzalutamide
  source: MESH
  identifier: C540278
diseases: []
figid_alias: PMC4156720__F1
redirect_from: /figures/PMC4156720__F1
figtype: Figure
---
